Nov 25, 2024
Autor: Luciano Giacaglia
Revista: Diabetes Care
Ref: Steven G. Johnson. Diabetes Care 21 October 2024; 47
(11): 1930–1940. https://doi.org/10.2337/dca24-0032
Semaglutida oral na doença hepática esteatótica metabólica em DM2 - Luciano Giacaglia - #Podcast 276
Nov 11, 2024
Autor: Luciano Giacaglia
Revista: Diabetes Obes Metab.
Ref: Arai T. Beneficial effect of oral semaglutide for type 2
diabetes mellitus in patients with metabolic dysfunction-associated
steatotic liver disease: A prospective, multicentre, observational
study. Diabetes Obes Metab. 2024 Nov;26(11):4958-4965....
Nov 7, 2024
Autor: Samuel Brito de Almeida
Revista: Sci Rep
Ref: Li S, Yuan S, Zhang J, Xu F, Zhu F. The effect of
periodic resistance training on obese patients with type 2 diabetic
nephropathy. Sci Rep. 2024 Feb 2;14(1):2761. doi:
10.1038/s41598-024-53333-4.
#####obesidade
Nov 4, 2024
Autor: Marília Izar Helfenstein Fonseca
Revista: Eur Heart J
Ref: Karagiannis AD. How low is safe? The frontier of very low
(<30 mg/dL) LDL cholesterol. Eur Heart J. 2021 Jun
7;42(22):2154-2169. doi: 10.1093/eurheartj/ehaa1080.